scholarly journals Phenomenological and existential contributions to the study of erectile dysfunction

2021 ◽  
Author(s):  
Chris A. Suijker ◽  
Corijn van Mazijk ◽  
Fred A. Keijzer ◽  
Boaz Meijer
Keyword(s):  
Erectile Dysfunction ◽  
Body Schema ◽  
Phenomenological Analysis ◽  
Current Medical ◽  
Diagnosis And Treatment ◽  
Phenomenology Of Perception ◽  
Medical Approach ◽  
Social Components

AbstractThe current medical approach to erectile dysfunction (ED) consists of physiological, psychological and social components. This paper proposes an additional framework for thinking about ED based on phenomenology, by focusing on the theory of sexual projection. This framework will be complementary to the current medical approach to ED. Our phenomenological analysis of ED provides philosophical depth and illuminates overlooked aspects in the study of ED. Mainly by appealing to Merleau-Ponty’s Phenomenology of Perception, we suggest considering an additional etiology of ED in terms of a weakening of a function of sexual projection. We argue that sexual projection can be problematized through cognitive interferences, changes in the ‘intentional arc’, and modifications in the subject’s ‘body schema’. Our approach further highlights the importance of considering the ‘existential situation’ of patients with ED. We close by reflecting briefly on some of the implications of this phenomenological framework for diagnosis and treatment of ED.

scholarly journals The blue pill (sildenafil) and its descendants: an overview

2017 ◽  
Vol 30 (3) ◽  
pp. 129-133
Author(s):  
Tomasz Krzanowski ◽  
Lila Dabkowska ◽  
Monika Wujec ◽  
Ewa Kedzierska
Keyword(s):  
Erectile Dysfunction ◽  
Current Medical ◽  
Medication Treatment ◽  
Phosphodiesterase Type 5 Inhibitor ◽  
Sexuality Study ◽  
The World ◽  
Severity Of The Disease ◽  
Phosphodiesterase Type ◽  
Medical Guidelines ◽  
Active Substances

AbstractAn increasing number of men around the world suffer from erectile dysfunction (ED). Indeed, according to the sexuality study conducted by Professor Izdebski, 1 out of 10 men in Poland suffers from ED. The problem is found among men of any age, however, 60% of all patients are between 40 and 60 years old, thus in their prime, and who still want to fully enjoy life. Not only do the effects of ED affect a man, but they have influence on his relationship and partner as well. In spite of a growing awareness within society, the problem remains perceived as embarrassing, which leads patients to treat themselves on their own, delaying a visit to their doctors. Meanwhile, in many cases, ED may be the first symptom of more serious diseases, such as diabetes, or result from the sideeffects of applied drugs. A breakthrough in the oral medication treatment of ED was observed when a new phosphodiesterase type 5 inhibitor (PDE-5-inhibitor) - sildenafil citrate (Viagra®) - was introduced. Nowadays, 5 active substances from this group are being applied. The current medical guidelines recommend PDE-5 inhibitors as the firstline therapy for most men with ED, irrespective of the cause and severity of the disease. Recently, sildenafil at the dose of 25 mg came into the market without prescription. This paper presents an overview and update of the PDE-5 inhibitors.

Diagnosis and Treatment of Erectile Dysfunction: The Process of Care Model

2000 ◽  
Vol 25 (Supplement) ◽  
pp. 4-10 ◽  
Author(s):  
HARIN PADMA-NATHAN ◽  
CHRISTOPHER FORREST
Keyword(s):  
Erectile Dysfunction ◽  
Diagnosis And Treatment ◽  
Process Of Care ◽  
Care Model
Sign in / Sign up

Export Citation Format

Share Document